D-0600-2022 Class II Terminated

Recalled by Perrigo Company PLC — Allegan, MI

FDA drug recall D-0600-2022 was initiated by Perrigo Company PLC on Oct 26, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier. The recall status is terminated (terminated Sep 29, 2023). Affected quantity: 561 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 2, 2022
Initiation Date
Oct 26, 2021
Termination Date
Sep 29, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
561 bottles

Product description

Children's Pain & Fever Acetaminophen, 160 mg per 5 mL Oral Suspension combo pack. DS SR APAP 160MG CHLD BBGM/DF CHRY/GRP. UPC: 3 70030 11637 9

Reason for recall

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Distribution pattern

Nationwide in the USA

Code information

Batch: 1EV1874, Exp 11/02/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0600-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0600-2022. Report a data issue: hello@regdatalab.com.